These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32657043)

  • 1. Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study.
    Gurka J; Piherova L; Majer F; Chaloupka A; Zakova D; Pelak O; Krebsova A; Peichl P; Krejci J; Freiberger T; Melenovsky V; Kautzner J; Kalina T; Sikora J; Kubanek M
    ESC Heart Fail; 2020 Oct; 7(5):2534-2543. PubMed ID: 32657043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.
    Xu J; Wang L; Liu X; Dai Q
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry.
    López-Sainz Á; Salazar-Mendiguchía J; García-Álvarez A; Campuzano Larrea O; López-Garrido MÁ; García-Guereta L; Fuentes Cañamero ME; Climent Payá V; Peña-Peña ML; Zorio-Grima E; Jordá-Burgos P; Díez-López C; Brugada R; García-Pinilla JM; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):479-486. PubMed ID: 30108015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency.
    Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J
    Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
    Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
    BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
    Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
    Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a
    Meinert M; Englund E; Hedberg-Oldfors C; Oldfors A; Kornhall B; Lundin C; Wittström E
    Ophthalmic Genet; 2019 Jun; 40(3):227-236. PubMed ID: 31264915
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
    Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAMP2 exon-copy number variations in Danon disease heterozygote female probands: Infrequent or underdetected?
    Majer F; Piherova L; Reboun M; Stara V; Pelak O; Norambuena P; Stranecky V; Krebsova A; Vlaskova H; Dvorakova L; Kmoch S; Kalina T; Kubanek M; Sikora J
    Am J Med Genet A; 2018 Nov; 176(11):2430-2434. PubMed ID: 30194816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon disease.
    Gourzi P; Pantou MP; Gkouziouta A; Kaklamanis L; Tsiapras D; Zygouri C; Constantoulakis P; Adamopoulos S; Degiannis D
    Eur J Med Genet; 2019 Jan; 62(1):77-80. PubMed ID: 29753918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alu-mediated Xq24 deletion encompassing CUL4B, LAMP2, ATP1B4, TMEM255A, and ZBTB33 genes causes Danon disease in a female patient.
    Majer F; Kousal B; Dusek P; Piherova L; Reboun M; Mihalova R; Gurka J; Krebsova A; Vlaskova H; Dvorakova L; Krihova J; Liskova P; Kmoch S; Kalina T; Kubanek M; Sikora J
    Am J Med Genet A; 2020 Jan; 182(1):219-223. PubMed ID: 31729179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
    Maron BJ; Roberts WC; Arad M; Haas TS; Spirito P; Wright GB; Almquist AK; Baffa JM; Saul JP; Ho CY; Seidman J; Seidman CE
    JAMA; 2009 Mar; 301(12):1253-9. PubMed ID: 19318653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmentary retinopathy can indicate the presence of pathogenic LAMP2 variants even in somatic mosaic carriers with no additional signs of Danon disease.
    Kousal B; Majer F; Vlaskova H; Dvorakova L; Piherova L; Meliska M; Langrova H; Palecek T; Kubanek M; Krebsova A; Gurka J; Stara V; Michaelides M; Kalina T; Sikora J; Liskova P
    Acta Ophthalmol; 2021 Feb; 99(1):61-68. PubMed ID: 32533651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danon disease: Gender differences in presentation and outcomes.
    Brambatti M; Caspi O; Maolo A; Koshi E; Greenberg B; Taylor MRG; Adler ED
    Int J Cardiol; 2019 Jul; 286():92-98. PubMed ID: 30857840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease.
    Wang Y; Bai M; Zhang P; Peng Y; Chen Z; He Z; Xu J; Zhu Y; Yan D; Wang R; Zhang Z
    Mol Genet Genomic Med; 2023 Sep; 11(9):e2216. PubMed ID: 37288668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
    Türkmen H; Uysal F; Bostan ÖM
    Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danon disease: a case report and literature review.
    Xu J; Li Z; Liu Y; Zhang X; Niu F; Zheng H; Wang L; Kang L; Wang K; Xu B
    Diagn Pathol; 2021 May; 16(1):39. PubMed ID: 33933120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review.
    Bottillo I; Giordano C; Cerbelli B; D'Angelantonio D; Lipari M; Polidori T; Majore S; Bertini E; D'Amico A; Giannarelli D; De Bernardo C; Masuelli L; Musumeci F; Avella A; Re F; Zachara E; d'Amati G; Grammatico P
    Cardiovasc Pathol; 2016; 25(5):423-31. PubMed ID: 27497751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.
    Zhang Y; Ren H; Zhou S
    Medicine (Baltimore); 2020 Oct; 99(40):e22640. PubMed ID: 33019488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
    Hong KN; Eshraghian EA; Arad M; Argirò A; Brambatti M; Bui Q; Caspi O; de Frutos F; Greenberg B; Ho CY; Kaski JP; Olivotto I; Taylor MRG; Yesso A; Garcia-Pavia P; Adler ED
    J Am Coll Cardiol; 2023 Oct; 82(16):1628-1647. PubMed ID: 37821174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.